|
⚲
|
| Keyboard |
| Janku Filip
✚
|
|
|---|---|
| CIK # | 0001862930 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001862930] | |
| 4 | [0001862930] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Monte Rosa Therapeutics Inc | |
| Janku Filip |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-02-23 | Sell | 9,189 | $19.50 | 179,186 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-05 | Sell | 3,155 | $15.17 | 47,861 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2026-01-02 | Grant | 31,000 | ||
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 139,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2025-01-02 | Grant | 36,000 | ||
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2025-01-02 | Grant | 161,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2024-09-13 | Grant | 30,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2024-01-02 | Grant | 121,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2023-01-03 | Grant | 135,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2022-12-15 | Grant | 36,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2022-10-31 | Grant | 36,000 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2022-03-01 | Grant | 86,500 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2021-06-23 | Grant | 387,069 | $0.00 |